ADVM’s Stock Dilemma: Adverum Biotechnologies Inc’s Market Performance and Outlook

In terms of market performance, Adverum Biotechnologies Inc had a somewhat regular. The highest value for the stock in the past year was $2.97 on 02/08/24, while the lowest value was $0.61 on 02/10/23.

52-week price history of ADVM Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Adverum Biotechnologies Inc’s current trading price is -41.75% away from its 52-week high, while its distance from the 52-week low is 183.61%. The stock’s price range during this period has fluctuated between $0.61 and $2.97. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.32 for the day, which was evidently lower than the average daily volume of 2.97 over the last three months.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Financial Performance and Market Capitalization

Adverum Biotechnologies Inc (ADVM) has experienced a quarterly rise of 88.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 174.78M.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0427, with a change in price of +0.1900. Similarly, Adverum Biotechnologies Inc recorded 952,579 in trading volume during the last 100 days, posting a change of +12.34%.

ADVM Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ADVM stands at 0.74. Similarly, the long-term debt-to-equity ratio is also 0.63.

ADVM Stock Stochastic Average

The raw stochastic average for Adverum Biotechnologies Inc over the last 50 days is presently at 44.39%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 42.86%. Further, the company’s Stochastic %K and %D values for the last 20 days were 65.43% and 80.82%, respectively.

ADVM Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 129.81%.However, over the last six months, we can see a stronger performance of -5.46%. Over the last 30 days, the price of ADVM has fallen by 98.85%. And in the last five days, it has surged by 21.83%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts